A. Gill

发表

Domain Architecture of a Calcium-Permeable AMPA Receptor in a Ligand-Free Conformation

Dean R. Madden, Charles R. Midgett, Avinash Gill, 2012, Front. Mol. Neurosci..

A targeted boost-and-sort immunization strategy using Escherichia coli BamA identifies rare growth inhibitory antibodies

D. Seshasayee, Jack Bevers, G. Nakamura, 2018, Scientific Reports.

Efficient ethanol production from brown macroalgae sugars by a synthetic yeast platform

Christine Nicole S. Santos, Hans Kristian Kotlar, Dennis J. Miller, 2013, Nature.

Anticorps anti-pd-1, compositions comprenant des anticorps anti-pd-1 et procédés d'utilisation d'anticorps anti-pd-1

A. Gill, A. Yam, R. Stafford, 2015 .

Susceptibility of Antibody CDR Residues to Chemical Modifications Can Be Revealed Prior to Antibody Humanization and Aid in the Lead Selection Process.

W. J. Galush, I. Hötzel, G. Lazar, 2018, Molecular pharmaceutics.

Conjugués d'anticorps anti-cd74, compositions comprenant des conjugués d'anticorps anti-cd74 et méthodes d'utilisations desdits conjugués d'anticorps anti-cd74

A. Gill, Xiaofan Li, A. Sato, 2017 .

In vitro Fab display: a cell-free system for IgG discovery

C. J. Murray, J. Fung, R. Stafford, 2014, Protein engineering, design & selection : PEDS.

Production of site-specific antibody-drug conjugates using optimized non-natural amino acids in a cell-free expression system.

C. J. Murray, Avinash Gill, E. Zimmerman, 2014, Bioconjugate chemistry.

Correlating AMPA receptor activation and cleft closure across subunits: crystal structures of the GluR4 ligand-binding domain in complex with full and partial agonists.

B. L. Jones, L. Henderson, D. Madden, 2008, Biochemistry.

Production, characterization, and in vivo half-life extension of polymeric IgA molecules in mice

W. Sandoval, J. Zorn, A. Estevez, 2019, mAbs.

RF1 attenuation enables efficient non-natural amino acid incorporation for production of homogeneous antibody drug conjugates

C. J. Murray, R. Stafford, A. Gill, 2017, Scientific Reports.

A targeted boost-and-sort immunization strategy using Escherichia coli BamA identifies rare growth inhibitory antibodies

D. Seshasayee, Jack Bevers, G. Nakamura, 2018, Scientific Reports.

Enhanced antimicrobial activity of engineered human lysozyme.

J. Weiner, C. Teneback, A. Gill, 2010, ACS chemical biology.

RF1 attenuation enables efficient non-natural amino acid incorporation for production of homogeneous antibody drug conjugates

C. J. Murray, R. Stafford, A. Gill, 2017, Scientific Reports.

Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain*

A. Crameri, A. Rajpal, J. Pons, 2016, The Journal of Biological Chemistry.

Structures of HCMV Trimer reveal the basis for receptor recognition and cell entry

A. Rohou, C. Arthur, C. Ciferri, 2021, Cell.

A parallel panning scheme used for selection of a GluA4-specific Fab targeting the ligand-binding domain.

J. Kastrup, D. Madden, A. Gill, 2016, International journal of biological macromolecules.

Crystal Structure of a Charge Engineered Human Lysozyme Having Enhanced Bactericidal Activity

D. Madden, A. Gill, K. Griswold, 2011, PloS one.

Enhanced Efficacy without Further Cleft Closure: Reevaluating Twist as a Source of Agonist Efficacy in AMPA Receptors

L. Henderson, D. Madden, A. Gill, 2010, The Journal of Neuroscience.

Purification and crystallization of a non-GluR2 AMPA-receptor ligand-binding domain: a case of cryo-incompatibility addressed by room-temperature data collection.

D. Madden, A. Gill, 2008, Acta crystallographica. Section F, Structural biology and crystallization communications.

Automated high throughput microscale antibody purification workflows for accelerating antibody discovery

Peng Luan, Sophia Lee, Tia A Arena, 2018, mAbs.